AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2016
Aug 3, 2016
29828_dirs_2016-08-03_a945da37-cc77-4f70-a6f3-9e03981c3dc2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2016-08-01
Reporting Person: MILLIGAN JOHN F (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-08-01 | Common Stock | M | 70000 | $20.74 | Acquired | 1128963 | Direct |
| 2016-08-01 | Common Stock | S | 70000 | $70.937 | Disposed | 1058963 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-08-01 | Non-qualified Stock Option (Right to Buy) | $20.74 | M | 70000 | Disposed | 2017-05-08 | Common Stock (70000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: Options vest over a five year period beginning 5/08/2008, the first anniversary of the grant. The options continue to vest in quarterly installments over the next four years, ending on 5/08/2012.
F3: Sale prices reported for the transactions reported here range from $79.53 to $80.14. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.